HRA Pharma - A fast-growing consumer healthcare company, building and developing strong OTC and consumer healthcare brands.
HRA PHARMA AND PERRIGO COMPANY CLOSE ACQUISITION DEAL.
Today, HRA Pharma and Perrigo officially closed their acquisition deal. Perrigo have issued a statement, which you can find via the link below.
Building on our strengths, focused on our future.
Our ambition for the years to come is to become one of the fastest growing global Consumer Healthcare companies, empowering people throughout the world to improve their lives by developing accessible, value added self-care solutions.
We invite you to take a look at our product portfolio in women’s health.
Please note that brand names may differ depending on where you live or practice. HRA Pharma’s products in your country: Regulatory status of the products may vary depending on the country. Please contact us to get more information.
Milestone step for Women in the UK.
We are delighted to inform you that Marketing authorization has been granted in the UK for Hana, a progestogen-only contraceptive pill containing 75 mcg of desogestrel, that will be available to buy in pharmacies without a prescription (information for UK market only).
In our HRA Pharma Wound Care portfolio we offer Compeed.
A global brand that offers a wide variety of high-quality solutions for preventing and treating blisters, bunions, callus, corns, cracked heels and cold sores. Visit the Compeed Website for more information.
HRA Pharma Rare Diseases, an affiliate “Devoted to the rare”, offering treatments for Cushing’s Syndrome and Adrenocortical Carcinoma.
At HRA Pharma Rare Diseases, we are a team of passionate people, dedicated to rare and ultra-rare diseases, serving the neglected rare disease communities; patients who are not being diagnosed promptly and have difficulty accessing life-saving medicines, as well as rare diseases’ specialists who are treating them.
Our mission is to continue fighting so no patient is left behind!